Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia.
Zhao X, Wu JF, Xiu QY, Wang C, Zhang DP, Huang JA, Xie CM, Sun SH, Lv XJ, Si B, Xiao ZK, Zhang YY. Zhao X, et al. Among authors: huang ja. Diagn Microbiol Infect Dis. 2014 Oct;80(2):141-7. doi: 10.1016/j.diagmicrobio.2013.11.008. Epub 2013 Nov 15. Diagn Microbiol Infect Dis. 2014. PMID: 25130297 Clinical Trial.
Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J, Xu JF, Liu YB, Xiao ZK, Huang JA, Si B, Sun SH, Xia QM, Wu XJ, Cao GY, Shi YG, Zhang YY. Zhang J, et al. Among authors: huang ja. J Infect Chemother. 2009 Oct;15(5):293-300. doi: 10.1007/s10156-009-0714-8. Epub 2009 Oct 24. J Infect Chemother. 2009. PMID: 19856067 Clinical Trial.
Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY, Huang HH, Ren ZY, Zheng HG, Yu YS, Lü XJ, Xiao ZK, Yang HF, Xiu QY, Chen BY, Yue HM, Hao QL, Huang JA, Ma H, Xiao W, Guo DY, Si B, Sun SH, Zhang W, Li QH, Shen HH, Duan J, Li HY, Yao WZ, Gu JM, Xia QM, Ying KJ, Liu A, Yang HP, Shi MH, Sun TY, Ding GH, Wu GM. Zhang YY, et al. Among authors: huang hh, huang ja. J Infect Chemother. 2009 Oct;15(5):301-11. doi: 10.1007/s10156-009-0713-9. Epub 2009 Oct 24. J Infect Chemother. 2009. PMID: 19856068 Clinical Trial.
Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis.
Zhang XL, Zhu QQ, Chen YH, Li XL, Chen F, Huang JA, Xu B. Zhang XL, et al. Among authors: huang ja. J Am Heart Assoc. 2018 Jan 20;7(2):e007165. doi: 10.1161/JAHA.117.007165. J Am Heart Assoc. 2018. PMID: 29353233 Free PMC article.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
331 results